Company Filing History:
Years Active: 2018
Title: James Edward Kitulagoda: Innovator in Neurological Treatments
Introduction
James Edward Kitulagoda is a notable inventor based in Hertfordshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for neurological disorders. With a total of 2 patents, his work focuses on innovative solutions for cognitive deficits associated with conditions such as Alzheimer-type dementia and dementia with Lewy bodies.
Latest Patents
Kitulagoda's latest patents include 4-azaindole derivatives, which serve as modulators of the muscarinic acetylcholine receptor (mAChR) M1. These compounds may be effective in preventing or modifying the symptoms of cognitive deficits linked to neurological disorders. His pharmaceutical compositions comprise a 4-azaindole derivative as an active ingredient, showcasing his commitment to advancing medical science.
Career Highlights
James Edward Kitulagoda is currently associated with Eisai R&D Management Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work is pivotal in addressing the challenges posed by cognitive impairments in patients suffering from various forms of dementia.
Collaborations
Throughout his career, Kitulagoda has collaborated with esteemed colleagues, including Andrew Payne and Jose Luis Castro Pineiro. These partnerships have further enriched his research and development efforts.
Conclusion
James Edward Kitulagoda stands out as a dedicated inventor whose work in neurological treatments has the potential to significantly impact the lives of individuals affected by cognitive disorders. His innovative approach and collaborative spirit continue to drive advancements in the field.